2018-25865. Bulk Manufacturer of Controlled Substances Application: Cayman Chemical Company  

  • Start Preamble

    ACTION:

    Notice of application.

    DATES:

    Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before January 28, 2019.

    ADDRESSES:

    Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.

    End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (“Assistant Administrator”) pursuant to section 7 of 28 CFR part 0, appendix to subpart R.

    In accordance with 21 CFR 1301.33(a), this is notice that on July 25, 2018, Cayman Chemical Company, 1180 East Ellsworth Road, Ann Arbor, Michigan 48108 applied to be registered as a bulk manufacturer for the basic classes of controlled substances:

    Controlled substanceDrug codeSchedule
    3-Fluoro-N-methylcathinone (3-FMC)1233I
    Cathinone1235I
    Methcathinone1237I
    4-Fluoro-N-methylcathinone (4-FMC)1238I
    Start Printed Page 60901
    Pentedrone (α-methylaminovalerophenone)1246I
    Mephedrone (4-Methyl-N-methylcathinone)1248I
    4-Methyl-N-ethylcathinone (4-MEC)1249I
    Naphyrone1258I
    N-Ethylamphetamine1475I
    N,N-Dimethylamphetamine1480I
    Fenethylline1503I
    Aminorex1585I
    4-Methylaminorex (cis isomer)1590I
    Gamma Hydroxybutyric Acid2010I
    Methaqualone2565I
    Mecloqualone2572I
    JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole)6250I
    SR-18 (Also known as RCS-8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole)7008I
    ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide)7010I
    5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone7011I
    AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide)7012I
    JWH-019 (1-Hexyl-3-(1-naphthoyl)indole)7019I
    MDMB-FUBINACA (Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate)7020I
    2-(1-(4-fluorobenzyl)-1Hinsazole-3-carboxamido)-3-methylbutanoate7021I
    AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide)7023I
    THJ-2201 [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone7024I
    5F-AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2yl)-1-(5-fluoropentyl)-1 H-indazole-3-carboxamide)7025I
    AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide7031I
    MAB-CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide)7032I
    5F-AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate)7033I
    5F-ADB; 5F-MDMB-PINACA (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate)7034I
    ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide)7035I
    MDMB-CHMICA, MMB-CHMINACA (Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate)7042I
    MMB-CHMICA, AMB-CHMICA (methyl 2-(1(cyclohexylmethyl)-1 H-indole-3-carboxamido)-3methylbutanoate)7044I
    APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide7048I
    5F-APINACA, 5F-AKB48 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide)7049I
    JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole)7081I
    5F-CUMYL-P7AICA (1-(5-fluoropentyl)-N-(2phenylpropan-2-yl)-1 H-pyrrolo[2,3-b]pyridine-3carboxamide)7085I
    4-CN-CUMYL-BUTINACA (1-(4-cyanobutyl)-N-(2phenylpropan-2-yl)-1 H-indazole-3-carboxamide)7089I
    SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole7104I
    JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole)7118I
    JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole)7122I
    UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone7144I
    JWH-073 (1-Butyl-3-(1-naphthoyl)indole)7173I
    JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole)7200I
    AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole)7201I
    JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole)7203I
    NM2201; CBL2201 (Naphthalen-1-yl 1-(5-fluoropentyl)1 H-indole-3-carboxylate)7221I
    PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate)7222I
    5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate)7225I
    Alpha-ethyltryptamine7249I
    Ibogaine7260I
    CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol)7297I
    CP-47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol)7298I
    Lysergic acid diethylamide7315I
    2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7)7348I
    Marihuana7360I
    Tetrahydrocannabinols7370I
    Mescaline7381I
    2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C-T-2 )7385I
    3,4,5-Trimethoxyamphetamine7390I
    4-Bromo-2,5-dimethoxyamphetamine7391I
    4-Bromo-2,5-dimethoxyphenethylamine7392I
    4-Methyl-2,5-dimethoxyamphetamine7395I
    2,5-Dimethoxyamphetamine7396I
    JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole)7398I
    2,5-Dimethoxy-4-ethylamphetamine7399I
    3,4-Methylenedioxyamphetamine7400I
    5-Methoxy-3,4-methylenedioxyamphetamine7401I
    N-Hydroxy-3,4-methylenedioxyamphetamine7402I
    3,4-Methylenedioxy-N-ethylamphetamine7404I
    3,4-Methylenedioxymethamphetamine7405I
    4-Methoxyamphetamine7411I
    5-Methoxy-N-N-dimethyltryptamine7431I
    Alpha-methyltryptamine7432I
    Diethyltryptamine7434I
    Dimethyltryptamine7435I
    Start Printed Page 60902
    Psilocybin7437I
    Psilocyn7438I
    5-Methoxy-N,N-diisopropyltryptamine7439I
    N-Ethyl-1-phenylcyclohexylamine7455I
    1-(1-Phenylcyclohexyl)pyrrolidine7458I
    1-[1-(2-Thienyl)cyclohexyl]piperidine7470I
    1-[1-(2-Thienyl)cyclohexyl]pyrrolidine7473I
    N-Benzylpiperazine7493I
    2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C-D)7508I
    2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E )7509I
    2-(2,5-Dimethoxyphenyl) ethanamine (2C-H)7517I
    2-(4-iodo-2,5-dimethoxyphenyl) ethanamine (2C-I)7518I
    2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C)7519I
    2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N)7521I
    2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C-P)7524I
    2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C-T-4 )7532I
    MDPV (3,4-Methylenedioxypyrovalerone)7535I
    2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25B-NBOMe)7536I
    2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C-NBOMe)7537I
    2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25I-NBOMe)7538I
    Methylone (3,4-Methylenedioxy-N-methylcathinone)7540I
    Butylone7541I
    Pentylone7542I
    alpha-pyrrolidinopentiophenone (α-PVP)7545I
    alpha-pyrrolidinobutiophenone (α-PBP)7546I
    AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole)7694I
    Acetyldihydrocodeine9051I
    Benzylmorphine9052I
    Codeine-N-oxide9053I
    Desomorphine9055I
    Etorphine (except HCl)9056I
    Codeine methylbromide9070I
    Dihydromorphine9145I
    Heroin9200I
    Morphine-N-oxide9307I
    Normorphine9313I
    U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide)9547I
    MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine))9560I
    Tilidine9750I
    Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide)9811I
    Para-Fluorofentanyl9812I
    3-Methylfentanyl9813I
    Alpha-methylfentanyl9814I
    Acetyl-alpha-methylfentanyl9815I
    N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide9816I
    Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide)9821I
    Butyryl Fentanyl9822I
    Para-fluorobutyryl fentanyl9823I
    4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide)9824I
    2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide9825I
    Para-chloroisobutyryl fentanyl9826I
    Isobutyryl fentanyl9827I
    Beta-hydroxyfentanyl9830I
    Beta-hydroxy-3-methylfentanyl9831I
    Alpha-methylthiofentanyl9832I
    3-Methylthiofentanyl9833I
    Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide)9834I
    Thiofentanyl9835I
    Beta-hydroxythiofentanyl9836I
    Para-methoxybutyryl fentanyl9837I
    Ocfentanil9838I
    Valeryl fentanyl9840I
    N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide9843I
    Cyclopropyl Fentanyl9845I
    Cyclopentyl fentanyl9847I
    Fentanyl related-compounds as defined in 21 CFR 1308.11&h)9850I
    Amphetamine1100II
    Methamphetamine1105II
    Lisdexamfetamine1205II
    Phenmetrazine1631II
    Methylphenidate1724II
    Amobarbital2125II
    Pentobarbital2270II
    Secobarbital2315II
    Start Printed Page 60903
    Phencyclidine7471II
    4-Anilino-N-phenethyl-4-piperidine (ANPP)8333II
    Phenylacetone8501II
    1-Piperidinocyclohexanecarbonitrile8603II
    Cocaine9041II
    Codeine9050II
    Etorphine HCl9059II
    Dihydrocodeine9120II
    Oxycodone9143II
    Hydromorphone9150II
    Ecgonine9180II
    Ethylmorphine9190II
    Hydrocodone9193II
    Levomethorphan9210II
    Levorphanol9220II
    Isomethadone9226II
    Meperidine9230II
    Meperidine intermediate-B9233II
    Methadone9250II
    Dextropropoxyphene, bulk (non-dosage forms)9273II
    Morphine9300II
    Thebaine9333II
    Oxymorphone9652II
    Thiafentanil9729II
    Alfentanil9737II
    Remifentanil9739II
    Sufentanil9740II
    Carfentanil9743II
    Tapentadol9780II
    Fentanyl9801II

    The company plans to bulk manufacture the listed controlled substances to produce forensic and research analytical reference standards for distribution to its customers.

    Start Signature

    Dated: November 16, 2018.

    John J. Martin,

    Assistant Administrator.

    End Signature End Supplemental Information

    [FR Doc. 2018-25865 Filed 11-26-18; 8:45 am]

    BILLING CODE 4410-09-P

Document Information

Published:
11/27/2018
Department:
Drug Enforcement Administration
Entry Type:
Notice
Action:
Notice of application.
Document Number:
2018-25865
Dates:
Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before January 28, 2019.
Pages:
60900-60903 (4 pages)
Docket Numbers:
Docket No. DEA-392
PDF File:
2018-25865.pdf